Abstract: Post-thoracotomy pain is very severe and may cause pulmonary complications. Thoracic epidural analgesia can greatly decrease the pain experience and its consequences. However, finding new methods to decrease the amount of administered opioids is an important issue of research. We aimed to evaluate the effect of adding epidural magnesium sulphate to bupivacaine and morphine on pain control and the amount of opioid consumption after thoracotomy. Eighty patients undergoing thoracotomy at a tertiary cardiothoracic referral centre were enrolled in a randomized, double-blind trial. Patients were randomly allocated to two groups. Bupivacaine (12.5 mg) and morphine (2 mg) were administered epidurally to all patients at the end of operation. Patients in the magnesium (Mg) group received epidural magnesium sulphate (50 mg), and patients in the control (C) group received normal saline as an adjuvant. Visual analogue scale (VAS) score and the amount of morphine consumption were measured during 24 hr post-operation. Thirty-nine patients in the Mg group and 41 patients in the C group completed the study. Patients in the Mg group had significantly less VAS score at recovery time (p < 0.05), 2 hr (p < 0.01) and 4 hr (p < 0.05) after surgery. The patient-controlled analgesia pump was started earlier in the C group than in the Mg group (p < 0.05). The amount of morphine needed in the Mg group was significantly lower than in the C group (5.64 AE 1.69 mg/24 hr versus 8.44 AE 3.98 mg/24 hr; p < 0.001). Pruritus was seen in the C group (9.7%) and absent in the Mg group (p < 0.05). Co-administration of magnesium sulphate with bupivacaine and morphine for thoracic epidural analgesia after thoracotomy leads to a reduction in post-operative pain score and the need for opioid administration.
Patients undergoing thoracotomy experience one of the most severe acute post-operative pains [1] . Considerable tissue damage caused by incision, constant respiratory movement of chest, and repetitive coughing are severe stimuli for post-thoracotomy pain [2, 3] . Inadequate pain management could result in diaphragmatic dysfunction, deep inspiration failure and consequently decreased functional residual capacity, ineffective cough, atelectasis, hypoxia and pneumonia [4] . Therefore, optimal post-thoracotomy pain management is required to secure adequate ventilation, coughing and reduction in postoperative respiratory complications [5] .
A variety of pain management methods such as thoracic epidural analgesia, paravertebral blocks, intercostal nerve blockade, systemic analgesia, cryoanalgesia, intrathecal administration of opioids and transcutaneous electrical nerve stimulation have been applied for post-thoracotomy pain relief [6] [7] [8] [9] [10] . Epidural analgesia is a common and acceptable technique in which administration of two or more medications increases analgesic effects and decreases adverse effects [5, 6] . Morphine and bupivacaine, as the most common opioid and local anaesthetic medications, are usually administered epidurally for this purpose [11, 12] .
The usage of magnesium for its antinociceptive effect is on the rise in anaesthesiology. This effect is explained by two main mechanisms: regulation of calcium entry into cell and antagonizing the N-methyl-D-aspartate (NMDA) receptors [13] . According to a meta-analysis of randomized controlled trials in different surgical procedures, systemic administration of perioperative magnesium as an analgesic adjunct lowers post-operative pain and consequently analgesic requirements [14] . Recently, a few studies on post-thoracotomy pain management (with limited number of patients) also showed positive effect of epidural magnesium on the pain reduction and lesser need for opioid administration [15] [16] [17] . However, the efficacy and safety of epidural magnesium is still a controversial issue. We designed this study to evaluate the effect of epidural magnesium sulphate as an adjuvant to bupivacaine and morphine on the severity of post-thoracotomy pain, amount of opioid consumption and occurrence of side effects. 
Materials and Methods
This double-blind, parallel-group study was carried out at the anaesthesiology department of Masih Daneshvari Hospital. The Institutional Review Board of National Research Institute of Tuberculosis and Lung Diseases (NRITLD) approved the study. The study registration number is NCT03343548.
Patient selection and blinding. Patients aged 16-65 years undergoing thoracotomy were recruited from December 2016 until November 2017. Patients with known hypersensitivity to magnesium sulphate, renal failure, hepatic dysfunction, severe obesity, psychotic or neurologic diseases, currently taking opioid or calcium channel blockers, and AV block degree II or III were excluded from the study. At any stages, patients' refusal to participate in the trial was also considered as exclusion criteria. Before thoracotomy, patients were instructed about visual analogue scale (VAS) and use of patientcontrolled epidural analgesia (PCEA) device. An anaesthesiologist performed all epidural infusion and PCEA set-up. All assessments were performed by an observer blinded to the groups' allocation.
Randomization and intervention. Before anaesthesia induction, each patient was placed in the lateral decubitus position. Then, an epidural catheter with a 0.2-lm filter was located in the thoracic T6-T7 or T7-T8 region using an 18-gauge Tuohy needle. Appropriate placement of epidural catheter was confirmed by loss of cold and pinprick sensations after infusion of 3 mL lidocaine 2% with epinephrine (1:200,000).
In the operation room, general anaesthesia was induced for all patients with fentanyl 2 lg/kg, midazolam 1-2 mg and sodium thiopental 5 mg/kg. Atracurium 0.6 mg/kg was used to facilitate tracheal intubation with a double-lumen endobronchial tube. Fibre-optic bronchoscopy was performed to confirm tracheal intubation accurate position. Anaesthesia was maintained with propofol and atracurium. Standard monitoring such as electrocardiography (ECG), invasive blood pressure and pulse oximeter was applied during anaesthesia.
Subsequently, patients underwent thoracotomy by posterolateral incision. A surgical team used the 3-trocar technique (212-mm-and 15-mm-diameter trocars) for all patients with the same materials. At the end of operation, patients were randomly allocated to two groups using a random number table: the magnesium (Mg) group received epidural magnesium sulphate (50 mg in 1 mL 0.9% saline) along with 12.5 mg bupivacaine and 2 mg morphine in 20 mL 0.9% saline, and the control (C) group received 1 mL 0.9% saline along with the same dose of bupivacaine and morphine. All patients were admitted to intensive care unit (ICU) after extubation. Then, PCEA device (size: 100 mL; infusion rate: 4 mL/hr; Canack Technology Co. Ltd., Vancouver, Canada) was set to deliver bupivacaine (62.5 mg/100 mL) and morphine (5 mg/ 100 mL) continuously. A patient-controlled injection was also programmed to deliver 0.5 mL bolus with a lockout of 15 min. between two consecutive boluses. PCEA device was started when the patients regained consciousness and had VAS score ≥4. Those patients complaining of pain (VAS score ≥4) even after performing PCEA were administered 2-5 mg intravenous rescue dose of morphine sulphate.
Outcome measures. Visual analogue scale score was measured during the first 24 hr post-operation (recovery time, 2, 4, 8, 12 and 24 hr after operation). Along with VAS, blood pressure (BP), heart rate (HR) and respiratory rate (RR) were monitored on the same occasions and recorded. Complications such as gastrointestinal bleeding or any other bleeding, respiratory distress, nausea, vomiting, pruritus, dizziness and renal functions were also checked during the first 24 hr after surgery. On day 1 post-operation, the time of initial usage of PCEA and required rescue doses of morphine sulphate were noted for each patient.
Primary outcome measures were VAS scores on post-operative evaluations. Secondary outcome measures were the time of initial usage of PCEA pump and cumulative morphine consumption during the first post-operative day.
Statistical analysis. The data were analysed by SPSS for Windows (version 22.0; SPSS, Chicago, IL, USA) software. A normal distribution of data was checked by the Kolmogorov-Smirnov test. Continuous variables were expressed as mean AE S.D., and categorical variables were reported as numbers (percentages)
With a two-sided type I error of 5% and study power at 80%, it was estimated that 34 patients would be needed in each group to detect a difference of 0.5 in mean VAS score between the Mg and C groups.
Results
General conditions. Eighty patients undergoing thoracotomy completed the study (39 patients in the Mg group and 41 patients in the C group), and no patient was withdrawn from the study. Patients were aged from 16 to 65 years, and 66.3% were male.
Patients in both the Mg and C groups were homogenous with reference to the age. There were no significant differences in terms of surgery type and duration of anaesthesia and surgery between the two groups (table 1). Pre-operative VAS scores were less than 3 and did not differ between the two groups.
Post-operative pain. Patients in the Mg group showed significantly lower VAS score on post-operative evaluations compared with the C group. More precisely, VAS score in the Mg group differed significantly from the C group at recovery (3.90 AE 1.89 versus 4.90 AE 1.93; p < 0.05), 2 hr (3.41 AE 1.12 versus 4.41 AE 1.34; p < 0.01) and 4 hr (2.79 AE 1.12 versus 3.68 AE 1.39; p < 0.05) after surgery ( fig. 1) . Patients in the Mg group disclosed significantly lower mean cumulative VAS scores throughout the first 24-hr post-thoracotomy period compared with the C group (2.59 AE 0.84 versus 3.26 AE 1.09; p < 0.01).
Analgesic demands.
The same amount of analgesics from PCEA was given to the patients in both the Mg and C groups. Compared with the C group, the time of initial usage of PCEA was delayed in the Mg group (64.49 AE 17.61 min. versus 49.02 AE 32.94 min; p < 0.05).
Five patients (12.8%) in the Mg group required rescue morphine sulphate, while 20 patients (48.8%) in the C group received rescue analgesia (p < 0.01). During the first postoperative day, the average morphine consumption (PCEA and intravenous) was significantly lower in the Mg group (5.64 AE 1.69 mg/24 hr) compared with the C group (8.44 AE 3.98 mg/24 hr; p < 0.001).
Haemodynamics and side effects. Haemodynamic instability and cardiac abnormalities were not observed during the study. Three patients (7.3%) in the C group and two patients (5.1%) in the Mg group experienced nausea/vomiting during the first 24 hr post-thoracotomy. One case of respiratory depression was reported in the C group. In addition, four patients (9.7%) complained of pruritus in the C group (p < 0.05). Bleeding occurred in four patients belonging to the Mg group and three patients in the C group. Other side effects including gastrointestinal bleeding, vertigo, atelectasis and drowsiness were not observed during the mentioned time.
Discussion
Epidural analgesia, with a local anaesthetic and opioid combination, is considered a safe and effective method for management of acute post-operative pain. However, research continues on adding other medications to the neuraxial block to improve the quality and prolong the duration of analgesia with minimal side effects [15, 18, 19] . The results of the present study demonstrated that epidural administration of magnesium sulphate as an adjuvant to morphine and bupivacaine reduced the post-thoracotomy pain and delayed the start of PCEA usage for 15 min.
The role of systemic magnesium, as an adjuvant analgesic agent for perioperative pain management, has been investigated in many studies [20] [21] [22] [23] . It has been shown that systemic administration of magnesium has variable analgesic efficacy that may be related to limited passage across the blood-brain barrier [24, 25] . Therefore, neuraxial administration of magnesium has emerged as an adjunctive analgesic for decreasing opioid consumption [26] [27] [28] .
The efficacy and safety of neuraxial magnesium has not yet been completely demonstrated. A quantitative review study reported an increase of 11.1 and 72.2% of the time to first analgesic request after intrathecal and epidural magnesium administration, respectively. However, the authors mentioned that dose-effect studies are necessary to reveal the safety profile of neuraxial magnesium [24] . Few studies have investigated the effect of neuraxial administration of magnesium in thoracic surgeries. In 2013, Ammar et al. showed that addition of 150 mg magnesium to bupivacaine for thoracic paravertebral block prolonged sensory block and analgesia duration. In addition, VAS score and need for morphine were decreased after thoracic surgery [17] . Recently, two studies reported epidural administration of magnesium as a useful adjunct to anaesthetic drugs in thoracic surgery. Kogler et al. injected 50 mg magnesium along with anaesthetic drugs via epidural catheter intra-and post-operatively. They found that the addition of magnesium in the epidural mixture of sufentanil and levobupivacaine led to more efficient intra-operative and postoperative analgesia [16] . Mohammad et al. also induced thoracic epidural analgesia using bupivacaine alone or with magnesium (50 mg) or clonidine in 60 patients and noticed that magnesium decreased the need for post-operative rescue analgesia. However, statistically significant differences were found between the magnesium versus clonidine and clonidine versus control group in terms of VAS score. They recommended larger studies on epidural administration of magnesium before its translation into routine clinical practice [15] . In our investigation, the same dose of magnesium for pain management after thoracotomy in larger number of patients was used and caused significant difference of VAS score between the Mg and C groups.
A quantitative review proved that intrathecal magnesium mostly reduces early post-operative pain scores [24] . Moreover, a meta-analysis of randomized, controlled trials showed the effect of systemic magnesium on early (0-4 hr) and late (24 hr) pain at rest [14] . In the current study, although patients in the Mg group showed a lower VAS score in the first 24 hr of the post-operative period, the difference between the groups was statistically significant only during the first 4 hr after operation. Our findings could be related to early effects of bolus epidural magnesium. Continuous infusion of epidural magnesium may increase the duration of analgesia effect, but there was doubt about physicochemical stability of the mixture of magnesium with bupivacaine and morphine in the PCEA used in our study.
Although thoracic epidural analgesia is often regarded as the gold standard for pain relief after thoracotomy, it has some disadvantages. The complications associated with placement of an epidural catheter and side effects related to the medications can occur with the use of post-operative epidural analgesia. Hypotension, motor block, nausea and vomiting, pruritus, respiratory depression and urinary retention are the common reported side effects [18, 29] . Similar to previous studies, no adverse reaction related to magnesium was found [15] [16] [17] 19, 30] , while the opioids' common side effects were predominantly observed in the C group. A significant difference was found between the two groups in terms of pruritus. Opioid-induced pruritus is considered as an adverse effect rather than an allergic reaction [31] . The prevalence of this adverse effect is dependent on the type, route and dosage of opioid used [32] . More morphine consumption in the C group caused occurrence of pruritus in 9.7% of the patients.
The limitation of the current study is the usage of a fixed dose of epidural magnesium due to the absence of scientific evidence regarding body-weight-based dosage of epidural magnesium. In addition, cough VAS score was not measured because of patients' incompliance. Cough increases pain in post-thoracotomy patients and may affect the result of VAS score in these patients [33, 34] .
In conclusion, co-administration of epidural magnesium with morphine and bupivacaine for post-operative epidural analgesia can reduce VAS score and the amount of opioid consumption without causing adverse effects. Further studies are needed to demonstrate the dose-response effect of epidural magnesium.
